Display options
Share it on

Int J Ment Health Syst. 2010 Jun 15;4:14. doi: 10.1186/1752-4458-4-14.

The contribution of Ghanaian pharmacists to mental healthcare: current practice and barriers.

International journal of mental health systems

Frances T Owusu-Daaku, Afia Fa Marfo, Edmund A Boateng

Affiliations

  1. Department of Clinical & Social Pharmacy, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. [email protected].

PMID: 20550668 PMCID: PMC2893087 DOI: 10.1186/1752-4458-4-14

Abstract

BACKGROUND: There is scant knowledge of the involvement of developing country pharmacists in mental healthcare. The objectives of this study were: to examine the existing role of Ghanaian community and hospital pharmacists in the management of mental illness, and to determine the barriers that hinder pharmacists' involvement in mental healthcare in Ghana.

METHOD: A respondent self-completion questionnaire was randomly distributed to 120 superintendent community pharmacists out of an estimated 240 pharmacists in Kumasi, Ashanti Region of Ghana. A purposive sampling method was utilized in selecting two public psychiatric hospital pharmacists in Accra, the capital city of Ghana for a face-to-face interview. A semi-structured interview guide was employed.

RESULTS: A 91.7% response rate was obtained for the community pharmacists' questionnaire survey. Approximately 65% of community pharmacists were not involved in mental health provision. Of the 35% who were, 57% counseled psychiatric patients and 44% of these dispensed medicines for mental illness. Perceived barriers that hindered community pharmacists' involvement in the management of mental health included inadequate education in mental health (cited by 81% of respondents) and a low level of encounter with patients (72%). The psychiatric hospital pharmacists were mostly involved in the dispensing of medicines from the hospital pharmacy.

CONCLUSION: Both community and hospital pharmacists in Ghana were marginally involved in the provision of mental healthcare. The greatest barrier cited was inadequate knowledge in mental health.

References

  1. Am J Hosp Pharm. 1977 Jun;34(6):604-8 - PubMed
  2. Am J Hosp Pharm. 1983 Sep;40(9):1541-2 - PubMed
  3. Res Social Adm Pharm. 2007 Dec;3(4):392-409 - PubMed
  4. Am J Health Syst Pharm. 2002 Nov 15;59(22):2221-5 - PubMed
  5. Aust New Zealand Health Policy. 2005 Dec 07;2:29 - PubMed
  6. Pharmacotherapy. 2003 Dec;23(12):1634-44 - PubMed
  7. Psychiatr Serv. 2008 Oct;59(10):1155-60 - PubMed
  8. Qual Saf Health Care. 2005 Jun;14(3):207-11 - PubMed
  9. Am J Hosp Pharm. 1985 Jun;42(6):1366-9 - PubMed
  10. Br J Psychiatry. 2004 Feb;184:176-81 - PubMed
  11. Int J Tuberc Lung Dis. 2000 Aug;4(8):730-6 - PubMed
  12. J Clin Psychiatry. 1979 Dec;40(12):501-3 - PubMed
  13. Psychiatr Serv. 2004 Dec;55(12):1434-6 - PubMed
  14. Psychiatr Serv. 2001 Dec;52(12):1615-20 - PubMed

Publication Types